Kidney Cancer Clinical Trial

Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome

Summary

This protocol concerns the approach to the localization, diagnosis of MEN1 and management of the tumor and the tissue samples in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor, investigations for MEN1 the subsequent management of the tumor and tissue samples for research.

View Full Description

Full Description

This protocol concerns the approach to the localization and management of the tumor in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor and the subsequent management of the tumor.

View Eligibility Criteria

Eligibility Criteria

INCLUSION CRITERIA:

New patients will be evaluated initially as described in the protocol entitled, "Diagnostic evaluation of patients with suspected abnormalities of gastric secretion" (89-DK-0005).

Only those patients that are being treated under the protocol entitled, "Medical Therapy of Zollinger-Ellison Syndrome" (protocol # 89-DK-0015) will be entered into this tumor localization and management protocol.

Study is for people with:

Kidney Cancer

Estimated Enrollment:

273

Study ID:

NCT00001254

Recruitment Status:

Completed

Sponsor:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

National Institutes of Health Clinical Center
Bethesda Maryland, 20892, United States

How clear is this clinincal trial information?

Study is for people with:

Kidney Cancer

Estimated Enrollment:

273

Study ID:

NCT00001254

Recruitment Status:

Completed

Sponsor:


National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.